Search Results

The Desperate Search for Insulin.

• Authors : JEFFRIES, VIRGINIA

Subjects: INSULIN; INSULIN derivatives; ISRAEL-Hamas War, 2023-

• Source: Newsweek Global. 8/2/2024, Vol. 183 Issue 3, p8-13. 6p. 5 Color Photographs, 1 Black and White Photograph.

Record details

Novo Nordisk A Seeks Patent for Glucose Sensitive Insulin Derivatives.

• Source: Global IP News: Pharmaceutical Patent News. 2024.

Record details

Analysis: PBMs Block Access to Lantus Biosimilars.

• Authors : Myshko, Denise

Subjects: *GOVERNMENT regulation; *EXECUTIVES; INSULIN derivatives

• Source: Formulary Watch. 7/20/2023, p1-2. 2p.

Record details

Improvement of blood glucose control and reduction of hypoglycemia, body weight, and C-reactive protein in type 1 diabetic patients treated with intensive insulin therapy with insulin analogs.

• Authors : Radenković, Saša; Golubović, Milena Velojić; Dimić, Dragan

Subjects: INSULIN derivatives; INSULIN aspart; BLOOD sugar analysis

• Source: Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia. Aug2024, Vol. 81 Issue 8, p480-490. 11p.

Record details

Gan & Lee Pharmaceuticals Seeks Patent for Insulin Derivatives.

• Source: Global IP News: Pharmaceutical Patent News. 2023.

Record details

State Intellectual Property Office of China Releases Gan & Lee Pharmaceuticals's Patent Application for Insulin Derivatives.

• Source: Global IP News: Pharmaceutical Patent News. 2023.

Record details

Gan & Lee Pharmaceuticals Submits Chinese Patent Application for Insulin Derivatives.

• Source: Global IP News: Pharmaceutical Patent News. 2023.

Record details

Patent Application Titled 'Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives' Published Online (USPTO 20230049480)

• Source: Obesity, Fitness & Wellness Week. March 11, 2023, 599

Record details

U.S. Patent and Trademark Office Releases Novo Nordisk's Patent Application for Glucose Sensitive Insulin Derivatives.

• Source: Global IP News: Medical Patent News. 2022.

Record details

Novo Nordisk Granted Patent for Insulin Derivatives and the Medical Uses Hereof.

• Source: Global IP News: Pharmaceutical Patent News. 2022.

Record details